TrialFrontiers in immunology2021

Recombinant Human C1 Esterase Inhibitor for the Management of Adverse Events Related to Intravenous Immunoglobulin Infusion in Patients With Common Variable Immunodeficiency or Polyneuropathy: A Pilot Open-Label Study.

Isaac R Melamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.